Penserra Capital Management LLC lifted its position in shares of CME Group Inc (NASDAQ:CME) by 193.9% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,064 shares of the financial services provider’s stock after buying an additional 10,598 shares during the quarter. Penserra Capital Management LLC’s holdings in CME Group were worth $2,733,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Meeder Asset Management Inc. raised its stake in CME Group by 84.8% in the second quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock valued at $129,000 after purchasing an additional 362 shares in the last quarter. Kaizen Advisory LLC raised its stake in CME Group by 151.9% in the second quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock valued at $134,000 after purchasing an additional 492 shares in the last quarter. Bbva Compass Bancshares Inc. acquired a new position in CME Group in the third quarter valued at about $134,000. Sun Life Financial INC raised its stake in CME Group by 267.7% in the second quarter. Sun Life Financial INC now owns 923 shares of the financial services provider’s stock valued at $151,000 after purchasing an additional 672 shares in the last quarter. Finally, Cornerstone Wealth Management LLC acquired a new position in CME Group in the second quarter valued at about $153,000. 84.28% of the stock is owned by institutional investors.
A number of research analysts recently commented on the company. Berenberg Bank set a $184.00 price target on CME Group and gave the company a “hold” rating in a research note on Thursday, September 20th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a research note on Tuesday, September 18th. Wells Fargo & Co boosted their price target on CME Group from $175.00 to $177.00 and gave the company a “market perform” rating in a research note on Friday, October 26th. Deutsche Bank reaffirmed a “buy” rating and issued a $192.00 price target (up previously from $185.00) on shares of CME Group in a research note on Thursday, October 11th. Finally, BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research note on Monday, July 16th. Five analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. CME Group presently has a consensus rating of “Buy” and an average price target of $182.69.
Shares of NASDAQ CME opened at $189.74 on Friday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.08. The stock has a market cap of $64.06 billion, a price-to-earnings ratio of 39.78, a price-to-earnings-growth ratio of 2.19 and a beta of 0.49. CME Group Inc has a 12 month low of $137.51 and a 12 month high of $190.43.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.42 by $0.03. The firm had revenue of $904.20 million during the quarter, compared to the consensus estimate of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. On average, sell-side analysts predict that CME Group Inc will post 6.64 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 27th. Shareholders of record on Monday, December 10th will be paid a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 1.48%. The ex-dividend date is Friday, December 7th. CME Group’s payout ratio is 58.70%.
In other news, CAO Jack J. Tobin sold 7,820 shares of the business’s stock in a transaction dated Wednesday, September 5th. The stock was sold at an average price of $174.87, for a total transaction of $1,367,483.40. Following the sale, the chief accounting officer now directly owns 17,534 shares in the company, valued at $3,066,170.58. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $172.30, for a total value of $51,690.00. Following the sale, the director now owns 42,912 shares in the company, valued at $7,393,737.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,572 shares of company stock valued at $4,206,309. Insiders own 0.43% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/11/10/penserra-capital-management-llc-boosts-stake-in-cme-group-inc-cme.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Featured Story: How Important is Technical Analysis of Stocks
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.